Markets
United States Antimony Stock Plunges 8% After Monday's Results-Call Transcript Filing
The metals company's third-quarter revenue rose 16.5%, but it recorded a $9.5 million net loss.
Markets
The metals company's third-quarter revenue rose 16.5%, but it recorded a $9.5 million net loss.
Markets
The Canadian drone maker's proposed Philippine joint venture still requires agreement on ownership, technology licensing and operations.
Markets
The database company plans automatic synchronization for live-data analysis and continued support for existing Firebolt customers.
Markets
Corrections including a satellite write-down are expected to add approximately $4.1 million to its previously reported first-half loss.
Markets
The royalty-funded drug developer also faces a leadership change, with its chief executive planning to retire by February 2027.
Markets
A $20 million Takeda milestone payment preceded the authorization, but management can choose to purchase no shares.
Markets
Warrant shares made up much of the reported holding as the DNA-medicine developer prepares to launch its newly approved treatment.
Markets
Revenue grew across every segment and region, while management added $30 million in investment spending.
Markets
Opera raised its full-year revenue outlook and plans to remove recurring depositary fees through a switch to ordinary shares.
Markets
North American subscribers fell even as fourth-quarter adjusted earnings improved, and the company plans to expand beyond pay TV.
Markets
The rally added $1 billion in market value, while Aecom expects construction projects to consume about $500 million in fiscal 2027.
Markets
Drug sales rose 26% from the second quarter, but non-cash valuation losses left Omeros with a reported loss.